By Professor Michael Proinsias Farrell

Conference Abstracts

Karlsson A; Gibbs D; Kelly G; Uporova J; Dietze PM; Bruno R; Lenton S; Salom C; Degenhardt L; Farrell M; Peacock A, 2019, 'TRENDS IN METHAMPHETAMINE FORMS AND ROUTES OF ADMINISTRATION AMONG PEOPLE WHO REGULARLY CONSUME DRUGS IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S59 - S59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Farnbach S; Foley C; Sara G; Shakeshaft A; Lappin J; Allan J; Courtney RJ; Farrell M; Dobbins T, 2019, 'WHO IS ACCESSING BOTH MENTAL HEALTH AND DRUG AND ALCOHOL SERVICES? MAPPING THE OVERLAP TO IDENTIFY OPPORTUNITIES FOR IMPROVING SPECIALISED CARE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S45 - S45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mammen K; Deacon RM; Holmes J; Dunlop AJ; Bruno R; Ryan A; Gardner L; Shakeshaft A; Farrell M; Phung N; Lintzeris N, 2017, 'THE CLINICAL UTILITY OF THE AUSTRALIAN TREATMENT OUTCOMES PROFILE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 50 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Cama E; Bruno R; Farrell M; Ali R; Lintzeris N; Peacock A; Kihas I; Hordern T; White N; Degenhardt L, 2014, 'PATTERNS OF OPIOID CONSUMPTION IN A COHORT OF PEOPLE WHO TAMPER WITH PHARMACEUTICAL OPIOIDS: BASELINE FINDINGS FROM THE NATIONAL OPIOID MEDICATION ABUSE DETERRENCE (NOMAD) STUDY', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Farrell M, 1992, 'Making the science and policy connection', in British Journal of Addiction, Vol. 87, pp. 138 - 139

Reports

Asare-Doku W; Stolk S; Peacock AMY; Shakeshaft A; Waller E; Nathan S; Economidis G; Ravulo J; Meo-Sewabu L; D'Este C; Thapa P; Abbott T; Satour T; Tulele L; Wilson K; Doran C; Mhey-Rivas T; Macpherson G; Lynch M; Taylor S; Santo T; Graham D; Baillie G; Tran A; Aiken A; Harwood E; Turner A; Reeve R; Degenhardt L; Farrell M; Santo Jr T, 2023, Monitoring and Evaluation of the Kava Pilot Program, National Drug and Alcohol Research Centre, UNSW, Sydney, https://www.odc.gov.au/resources/publications/monitoring-and-evaluation-kava-pilot-program

Sutherland R; Karlsson A; King C; Uporova J; Chandrasena U; Jones F; Gibbs D; Price O; Dietze P; Lenton S; Salom C; Bruno R; Wilson J; Grigg J; Daly C; Thomas N; Radke S; Stafford L; Degenhardt L; Farrell M; Peacock A, 2023, Australian Drug Trends 2023: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/1qta-pe36, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2023-key-findings-national-ecstasy-and-related-drugs-reporting

Sutherland R; Uporova J; King C; Chandrasena U; Karlsson A; Jones F; Gibbs D; Price O; Dietze P; Lenton S; Salom C; Bruno R; Wilson J; Agramunt S; Daly C; Thomas N; Radke S; Stafford L; Degenhardt L; Farrell M; Peacock A, 2023, Australian Drug Trends 2023: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/1tj1-8454, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2023-key-findings-national-illicit-drug-reporting-system-idrs

Shahbazi J; Farrell M; Byrne J; Ali R; Puszka B; Lim XQ; Cook J; Weiss R; Rodgers C; Dunlop A; Lintzeris N; Nielsen S; Grebely J; Zahra E; Degenhardt L; Byrne M, 2023, Considerations for delivering extended-release buprenorphine for opioid dependence in Australia: Preliminary lessons from the Community Long-Acting Buprenorphine (CoLAB) trial, NATIONAL DRUG AND ALCOHOL RESEARCH CENTRE, UNIVERSITY OF NEW SOUTH WALES, SYDNEY, 2020, RANDWICK, 355, http://dx.doi.org/10.26190/zemp-dx93

Chidwick K; Bharat C; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Real-world dosing intervals of long-acting buprenorphine for opioid agonist treatment., UNSW Sydney, Sydney, 345, http://dx.doi.org/10.26190/ayet-f348, https://ndarc.med.unsw.edu.au/resource/real-world-dosing-intervals-long-acting-buprenorphine-opioid-agonist-treatment

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in New South Wales, 2013-2022, UNSW Sydney, Sydney, 347, http://dx.doi.org/10.26190/rzmn-a864, https://ndarc.med.unsw.edu.au/resource/nsw-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Queensland, 2013-2022, UNSW Sydney, Sydney, 349, http://dx.doi.org/10.26190/ybm1-3f83, https://ndarc.med.unsw.edu.au/resource/qld-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in South Australia, 2013-2022, UNSW Sydney, Sydney, 350, http://dx.doi.org/10.26190/y21d-yd24, https://ndarc.med.unsw.edu.au/resource/sa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Tasmania, 2013-2022, UNSW Sydney, Sydney, 351, http://dx.doi.org/10.26190/q6zj-fx75, https://ndarc.med.unsw.edu.au/resource/tas-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Australian Capital Territory, 2013-2022, UNSW Sydney, Sydney, 346, http://dx.doi.org/10.26190/16m9-6z16, https://ndarc.med.unsw.edu.au/resource/ndarc-technical-reports-345-353

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Northern Territory, 2013-2022, UNSW Sydney, Sydney, 348, http://dx.doi.org/10.26190/mt8r-kd57, https://ndarc.med.unsw.edu.au/resource/nt-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Victoria, 2013-2022, UNSW Sydney, Sydney, 352, http://dx.doi.org/10.26190/gjpp-py45, https://ndarc.med.unsw.edu.au/resource/vic-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Western Australia, 2013-2022, UNSW Sydney, Sydney, 353, http://dx.doi.org/10.26190/ftbz-w461, https://ndarc.med.unsw.edu.au/resource/wa-trends-use-opioid-agonist-treatment-australia-2013-2022

Asare-Doku W; Macdonald C; Ottaviano S; Degenhardt L; Farrell M, 2023, Review of interventions to treat drug use disorders among girls and women in the criminal justice system in low- and middle-income countries, https://www.unodc.org/documents/commissions/CND/CND_Sessions/CND_66/ECN72023_CRP10_2304065E.pdf

McKetin R; Thapa P; Uthurralt N; Bo A; Degenhardt L; Farrell M; Mounteney J; Griffiths P; Degan T, 2023, An Overview Of The Evidence For Substance Use Interventions, NDARC, Sydney, http://dx.doi.org/10.26190/yb4b-1c31, https://ndarc.med.unsw.edu.au/resource/overview-evidence-substance-use-interventions

Brothers T; Degenhardt L, 2022, Time periods of altered risk for severe injection drug use-associated skin and soft-tissue infections: protocol for a self-controlled case series in New South Wales, Australia, 2001-2018, UCL Press, http://dx.doi.org/10.14324/000.rp.10157481, http://dx.doi.org/10.14324/000.rp.10157481

Sutherland R; Uporova J; Karlsson A; Price O; Chandrasena U; Swanton R; Gibbs D; Dietze P; Lenton S; Salom C; Grigg J; Wilson Y; Eddy S; Hall C; Daly C; Thomas N; Juckel J; Degenhardt L; Farrell M; Peacock A, 2021, Australian Drug Trends 2021: Key Findings from the National Ecstasy and related Drug Reporting System (EDRS) Interviews, NDARC, Sydney, http://dx.doi.org/10.26190/t6sh-g213

Sutherland R; Uporova J; Peacock A; Udesha C; Price O; Karlsson A; Gibbs D; Swanton R; Lenton S; Woods E; Farrell M; Bruno R; Dietze P; Salom C; Thomas N; Daly C; Juckel J; Agramunt S; Wilson Y; Degenhardt L; Moon C, 2021, Australian Drug Trends 2021: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews, NDARC, Sydney, http://dx.doi.org/10.26190/4p6r-jq88

Peacock A; Price O; Dietze P; Bruno R; Salom C; Lenton S; Uporova J; Karlsson A; Chan R; Gibbs D; Grigg J; Daly C; Hall C; Wilson T; Degenhardt L; Farrell M, 2020, Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia: Findings from the Ecstasy and Related Drugs Reporting System 2020, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5f74257af29e4

Peacock A; Price O; Dietze P; Bruno R; Salom C; Lenton S; Swanton R; Uporova J; Karlsson A; Chan R; Gibbs D; Grigg J; Daly C; Hall C; Wilson T; Degenhardt L; Farrell M, 2020, Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia: Preliminary findings from the Ecstasy and Related Drugs Reporting System 2020, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5ef1628d8e50c

Chrzanowska A; Gisev N; Price O; Sutherland R; Memedovic S; Degenhardt L; Farrell M; Peacock A, 2020, Tapentadol use and harms in Australia: Analysis of opioid sales data and sentinel survey data from people who inject drugs, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5ef15b883c0ac

Peacock A; Farrell M; Muscat C; Degenhardt L, 2020, Viability of an Early Warning System (ViEWS) study: Final report, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5e586c51e3059

Peacock A; Karlsson T; Uporova J; Gibbs D; Swanton R; Kelly G; Price O; Bruno R; Dietze P; Lenton S; Salom C; Degenhardt L; Farrell M, 2019, Australian Drug Trends 2019: Key findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5da51c1740a16

Peacock A; Uporova J; Karlsson T; Gibbs D; Swanton R; Kelly G; Price O; Bruno R; Dietze P; Lenton S; Salom C; Degenhardt L; Farrell M, 2019, Australian Drug Trends 2019: Key findings from the National Illicit Drug Reporting System (IDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5da521d347daf

Gibbs D; Grebely J; Larney S; Butler K; Sutherland R; Starr M; Karlsson A; Uporova J; Degenhardt L; Farrell M; Peacock A, 2019, Self-report and serological HCV status amongst people who inject drugs in NSW and ACT, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Drug Trends Bulletin August 2019, http://dx.doi.org/10.26190/5d788a487ac61, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/4.%20DBS%20and%20HCV%20self%20report%20bulletin.pdf

Sutherland R; Memedovic S; Degenhardt L; Farrell M; Peacock A, 2019, Tapentadol use among people who regularly inject drugs in Australia, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, https://ndarc.med.unsw.edu.au/resource/tapentadol-use-among-people-who-regularly-inject-drugs-australia

Peacock A; Gibbs D; Karlsson A; Uporova J; Sutherland R; Bruno R; Dietze P; Lenton S; Alati R; Degenhardt L; Farrell M, 2018, Ecstasy and Related Drugs Reporting System (EDRS) Interviews: Background and Methods, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/sites/default/files/National%20EDRS%20Interviews%20Method%20and%20Background.pdf

Peacock A; Gibbs D; Sutherland R; Uporova J; Karlsson A; Bruno R; Dietze P; Lenton S; Alati R; Degenhardt L; Farrell M, 2018, Illicit Drug Reporting System (IDRS) Interviews: Background and Methods, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/sites/default/files/National%20IDRS%20Interviews%20Background%20and%20Methods%202018.pdf

Peacock A; Gibbs D; Sutherland R; Uporova J; Karlsson T; Bruno R; Dietze P; Lenton S; Alati R; Degenhardt L; Farrell M, 2018, Australian Drug Trends 2018: Key findings from the National Illicit Drug Reporting System (IDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2018-key-findings-national-illicit-drug-reporting-system-idrs

Preprints

Saxby K; Ireland A; Ghijben P; Sweeney R; Sia K-L; Chen E; Farrell M; McRobbie H; Courtney R; Petrie D, 2022, Household composition, smoking cessation and relapse: results from a prospective longitudinal Australian cohort, , http://dx.doi.org/10.1101/2022.01.03.22268695

Yang C; Li Y; Trottier M; Farrell M; Rai V; Salo-Mullen E; Gallagher D; Stadler Z; Klift HVD; Zhang L, 2020, Insertion of an SVA Element in MSH2 as a Novel Cause of Lynch Syndrome, , http://dx.doi.org/10.22541/au.160619405.59308303/v1

Other

Campbell G; Hall W; Degenhardt L; Dobbins T; Farrell M, 2018, Cannabis use and non-cancer chronic pain – Authors' reply, , http://dx.doi.org/10.1016/S2468-2667(18)30182-8

Back to profile page